Corona Remedies announces IPO opening on 8 December 2025

Corona Remedies (CRL) has announced that the Bid/Offer period for its initial public offering (IPO) of equity shares will open on Monday, 8 December 2025 and close on Wednesday, 10 December 2025. The Anchor Investor Bidding Date is scheduled for Friday, 5 December 2025.

The company has set the price band at ₹1,008 to ₹1,062 per equity share. Bids can be made for a minimum of 14 equity shares and in multiples of 14 equity shares thereafter.

The offer comprises an offer for sale (OFS) of up to [●] equity shares of face value ₹10 each, aggregating up to ₹6,553.71 million. The OFS includes up to [●] equity shares aggregating up to ₹1,298.41 million by Dr Kirtikumar Laxmidas Mehta (Promoter Selling Shareholder); up to [●] equity shares aggregating up to ₹766.07 million by Minaxi Kirtikumar Mehta (Promoter Group Selling Shareholder); up to [●] equity shares aggregating up to ₹103.87 million by Dipabahen Niravkumar Mehta (Promoter Group Selling Shareholder); up to [●] equity shares aggregating up to ₹103.87 million by Brinda Ankur Mehta (Promoter Group Selling Shareholder); up to [●] equity shares aggregating up to ₹4,046.00 million by Sepia Investments Limited (Investor Selling Shareholder); up to [●] equity shares aggregating up to ₹151.25 million by Anchor Partners (Investor Selling Shareholder); and up to [●] equity shares aggregating up to ₹84.24 million by Sage Investment Trust (Investor Selling Shareholder).

JM Financial, IIFL Capital Services and Kotak Mahindra Capital Company are the Book Running Lead Managers to the offer.

The post Corona Remedies announces IPO opening on 8 December 2025 appeared first on Express Pharma.